Doctors in Hangzhou, Zhejiang province, have successfully completed the world's largest clinical study of involving the use ...

Fratricide-resistant CD7 CAR-T therapy by NUS proves effective in treating relapsed or refractory T-cell leukaemia ...

The CD7 CAR)-T cell therapy has demonstrated potential in treating patients with relapsed or refractory T-cell leukaemia.

Dr Oh added that about 80 per cent of such cases respond to conventional treatments such as chemotherapy and bone marrow ...

All youngsters in a new study have cancer that relapses or is resistant to conventional treatments, such as chemotherapy or ...

A new cell therapy, targeting CD7 in leukemia cells, gives a potentially effective treatment for patients with T-cell acute ...

撰文丨王聪编辑丨王多鱼排版丨水成文2024年10月4日，Nature 官网头条发布了一篇题为：World-first therapy using donor cells sends autoimmune diseases into remission ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

B-cell activating factor receptor (BAFF-R) chimeric antigen receptor (CAR) T-cell therapy incited cytotoxic effects on both ...

Car-T cell therapy has changed the face of many cancer treatments, but the level of customization it requires still comes ...

北京时间2024年7月16日在线发表在Cell，是由海军军医大学第二附属医院（上海长征医院）徐沪济教授团队领衔，华东师范大学、浙江大学医学院第二附属医院的研究人员共同合作，利用CRISPR-Cas9基因编辑技术对健康供体来源的靶向CD19的CAR-T细胞进行基因工程改造，开发出了新一代异体通用型CAR-T疗法，帮助3名风湿免疫性疾病患者达到长期缓解。

Reprogrammed stem cells are being tested in at least 50 clinical trials around the globe, and the first approved therapy ...